— Know what they know.
Not Investment Advice

300439.SZ SHZ

Medicalsystem Biotechnology Co., Ltd.
1W: +1.7% 1M: +7.7% 3M: +22.8% YTD: -1.0% 1Y: -13.0% 3Y: -5.9% 5Y: -45.6%
¥10.25 ($1.53)
+0.11 (+1.08%)
 
SHZ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 64 · ¥3.9B mcap · 345M float · 1.09% daily turnover

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Sep 30, 2026
DCF
4
ROE
3
ROA
3
D/E
4
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. 300439.SZ receives an overall rating of B+. Strongest factors: DCF (4/5), D/E (4/5), P/B (4/5). Areas of concern: P/E (1/5).
Rating Change History
DateFromTo
2026-08-21 A- B+
2026-08-17 B+ A-
2026-07-20 A- B+
2026-07-17 B+ A-
2026-07-01 A- B+
2026-05-25 B+ A-
2026-05-06 None ADDED
2026-05-05 EXISTED None
2026-04-30 A- B+
2026-04-28 B+ A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 52 Grade B
Profitability
23
Balance Sheet
98
Earnings Quality
66
Growth
26
Value
60
Momentum
59
Safety
100
Cash Flow
65
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. 300439.SZ scores highest in Safety (100/100) and lowest in Profitability (23/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.16
Safe Zone
Piotroski F-Score
5/9
✓ ✓ ✗ ✓ ✗ ✓ ✗ ✗ ✓
Beneish M-Score
-1.48
Possible Manipulator
Ohlson O-Score
-10.10
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 95.6/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 3.46x
Accruals: -4.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. 300439.SZ scores 4.16, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. 300439.SZ scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. 300439.SZ's score of -1.48 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. 300439.SZ's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. 300439.SZ receives an estimated rating of AAA (score: 95.6/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). 300439.SZ's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
58.17x
PEG
-1.20x
P/S
2.42x
P/B
1.34x
P/FCF
37.44x
P/OCF
13.38x
EV/EBITDA
11.83x
EV/Revenue
1.36x
EV/EBIT
40.94x
EV/FCF
26.21x
Earnings Yield
2.16%
FCF Yield
2.67%
Shareholder Yield
1.88%
Graham Number
$5.46
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 58.2x earnings, 300439.SZ is priced for high growth expectations. Graham's intrinsic value formula yields $5.46 per share, 88% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.229
NI / EBT
×
Interest Burden
1.029
EBT / EBIT
×
EBIT Margin
0.033
EBIT / Rev
×
Asset Turnover
0.443
Rev / Assets
×
Equity Multiplier
1.237
Assets / Equity
=
ROE
2.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. 300439.SZ's ROE of 2.3% is driven by Asset Turnover (0.443), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.23 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$1.48
Price/Value
5.44x
Margin of Safety
-444.03%
Premium
444.03%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with 300439.SZ's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. 300439.SZ trades at a 444% premium to its adjusted intrinsic value of $1.48, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 58.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$10.25
Median 1Y
$9.05
5th Pctile
$4.67
95th Pctile
$17.59
Ann. Volatility
40.3%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 8.7% 9.0% 7.4% 8.1% 8.7% 8.2% 8.0% 8.9% 8.6% 9.8% 9.8% 9.5% 9.0% 9.1% 7.3% 4.7% 3.2% 2.1% 2.2% 2.3% 2.29%
ROA 5.0% 5.2% 4.8% 5.2% 5.8% 5.5% 5.7% 6.4% 6.3% 7.3% 7.6% 7.4% 7.0% 7.2% 6.0% 3.8% 2.6% 1.7% 1.9% 1.9% 1.86%
ROIC 7.4% 9.3% 8.3% 9.5% 10.4% 9.7% 9.6% 11.1% 10.6% 13.1% 12.5% 12.0% 11.4% 11.7% 9.1% 6.2% 4.0% 1.2% 0.5% 1.1% 1.07%
ROCE 9.0% 9.7% 9.6% 10.2% 10.4% 9.6% 9.1% 9.9% 9.9% 11.0% 11.0% 10.5% 9.9% 9.4% 7.6% 4.8% 2.7% 1.6% 1.7% 1.8% 1.76%
Gross Margin 38.1% 39.0% 38.3% 36.6% 39.6% 36.3% 39.4% 49.6% 45.7% 39.8% 42.3% 50.8% 44.4% 39.3% 39.8% 41.9% 38.1% 24.8% 38.5% 33.0% 32.99%
Operating Margin 8.5% 3.7% 14.0% 12.7% 10.8% 1.0% 15.5% 23.9% 13.6% 3.3% 17.7% 21.8% 13.8% 5.2% 9.1% 5.7% -0.1% -8.9% 6.5% 6.7% 6.67%
Net Margin 6.6% 1.3% 12.0% 10.8% 9.3% -0.8% 14.5% 21.3% 11.2% 6.5% 16.4% 21.2% 10.0% 10.0% 8.1% 7.3% 0.9% 0.7% 9.0% 6.2% 6.24%
EBITDA Margin 19.2% 16.3% 23.9% 20.1% 17.7% 8.3% 25.9% 34.5% 22.1% 19.0% 26.8% 26.4% 13.2% 25.3% 8.9% 6.5% 11.2% 9.3% 9.9% 14.9% 14.92%
FCF Margin 12.8% 13.9% 10.3% 4.9% 2.2% 3.5% 11.0% 14.9% 19.1% 20.3% 14.6% 12.9% 8.0% -1.3% -2.1% 1.2% 7.9% 5.0% 6.0% 5.2% 5.17%
OCF Margin 21.3% 22.9% 18.6% 14.7% 13.6% 15.7% 22.8% 30.4% 35.4% 35.2% 32.0% 27.1% 21.3% 23.1% 21.2% 26.0% 29.7% 17.5% 16.8% 14.5% 14.48%
ROE 3Y Avg snapshot only 5.35%
ROE 5Y Avg snapshot only 6.50%
ROA 3Y Avg snapshot only 4.33%
ROIC 3Y Avg snapshot only 7.48%
ROIC Economic snapshot only 0.72%
Cash ROA snapshot only 6.36%
Cash ROIC snapshot only 11.49%
CROIC snapshot only 4.10%
NOPAT Margin snapshot only 1.35%
Pretax Margin snapshot only 3.41%
R&D / Revenue snapshot only 7.09%
SGA / Revenue snapshot only 23.14%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 35.44 43.86 33.10 23.41 19.79 21.47 23.11 18.56 19.86 16.84 13.33 13.31 17.00 15.31 19.64 29.23 42.07 59.82 55.64 46.24 58.173
P/S Ratio 2.69 3.50 2.50 1.87 1.71 1.71 1.93 1.94 2.17 2.29 1.88 1.87 2.35 2.27 2.51 2.61 2.69 2.46 2.40 1.94 2.415
P/B Ratio 2.62 3.35 2.38 1.84 1.65 1.70 1.79 1.59 1.66 1.59 1.26 1.22 1.48 1.34 1.38 1.35 1.34 1.28 1.24 1.05 1.343
P/FCF 21.08 25.10 24.26 38.03 79.54 48.26 17.46 12.95 11.37 11.31 12.92 14.52 29.40 -178.46 -120.07 211.31 34.17 48.97 40.13 37.44 37.442
P/OCF 12.64 15.27 13.43 12.73 12.58 10.89 8.44 6.38 6.14 6.52 5.87 6.88 10.99 9.83 11.86 10.03 9.07 14.05 14.34 13.38 13.381
EV/EBITDA 13.76 16.04 11.90 8.84 8.06 8.42 9.43 7.71 8.21 7.11 5.60 5.95 8.86 7.85 11.13 15.49 16.98 21.10 20.51 11.83 11.831
EV/Revenue 2.65 3.37 2.43 1.77 1.58 1.48 1.68 1.60 1.80 1.82 1.45 1.41 1.91 1.79 2.06 2.05 2.16 1.91 1.90 1.36 1.356
EV/EBIT 26.47 30.81 22.80 16.47 14.17 14.72 16.68 12.95 13.56 11.19 8.60 8.55 11.76 10.97 14.53 21.49 38.26 60.44 56.07 40.94 40.944
EV/FCF 20.73 24.19 23.61 35.99 73.32 41.78 15.20 10.71 9.45 8.98 9.94 10.98 23.90 -141.28 -98.33 166.29 27.37 38.09 31.80 26.21 26.208
Earnings Yield 2.8% 2.3% 3.0% 4.3% 5.1% 4.7% 4.3% 5.4% 5.0% 5.9% 7.5% 7.5% 5.9% 6.5% 5.1% 3.4% 2.4% 1.7% 1.8% 2.2% 2.16%
FCF Yield 4.7% 4.0% 4.1% 2.6% 1.3% 2.1% 5.7% 7.7% 8.8% 8.8% 7.7% 6.9% 3.4% -0.6% -0.8% 0.5% 2.9% 2.0% 2.5% 2.7% 2.67%
Price/Tangible Book snapshot only 1.094
EV/OCF snapshot only 9.367
EV/Gross Profit snapshot only 4.049
Acquirers Multiple snapshot only 121.783
Shareholder Yield snapshot only 1.88%
Graham Number snapshot only $5.46
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.84 1.89 2.02 1.92 2.02 2.11 2.40 2.39 2.47 2.72 3.11 3.05 3.07 2.73 3.29 3.07 3.12 3.03 3.46 3.10 3.096
Quick Ratio 1.63 1.69 1.77 1.92 1.79 1.89 2.14 2.13 2.20 2.35 2.70 2.63 2.62 2.30 2.78 2.64 2.70 2.66 2.99 2.74 2.740
Debt/Equity 0.24 0.21 0.20 0.17 0.17 0.13 0.10 0.07 0.06 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.04 0.03 0.02 0.03 0.031
Net Debt/Equity -0.04 -0.12 -0.06 -0.10 -0.13 -0.23 -0.23 -0.28 -0.28 -0.33 -0.29 -0.30 -0.28 -0.28 -0.25 -0.29 -0.27 -0.28 -0.26 -0.32 -0.316
Debt/Assets 0.16 0.13 0.13 0.12 0.12 0.09 0.07 0.05 0.05 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.03 0.02 0.02 0.03 0.025
Debt/EBITDA 1.29 1.02 1.01 0.88 0.90 0.72 0.59 0.42 0.38 0.15 0.14 0.13 0.14 0.17 0.12 0.17 0.58 0.60 0.41 0.51 0.506
Net Debt/EBITDA -0.23 -0.60 -0.33 -0.50 -0.68 -1.30 -1.41 -1.62 -1.67 -1.85 -1.68 -1.91 -2.04 -2.07 -2.46 -4.19 -4.22 -6.03 -5.37 -5.07 -5.071
Interest Coverage 7.18 8.41 8.86 12.00 14.52 23.49 45.90 46.74 64.57 28.73 33.06 36.81 37.17 112.89 90.44 89.89 34.20 17.16 20.04 15.94 15.937
Equity Multiplier 1.54 1.53 1.46 1.47 1.45 1.43 1.35 1.33 1.32 1.29 1.23 1.24 1.23 1.26 1.21 1.24 1.24 1.25 1.20 1.24 1.235
Cash Ratio snapshot only 1.628
Debt Service Coverage snapshot only 55.153
Cash to Debt snapshot only 11.021
FCF to Debt snapshot only 0.892
Defensive Interval snapshot only 1145.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.65 0.66 0.63 0.66 0.67 0.69 0.69 0.61 0.57 0.53 0.54 0.53 0.51 0.48 0.47 0.43 0.41 0.42 0.43 0.44 0.443
Inventory Turnover 5.11 5.76 5.58 13.76 6.61 7.23 6.47 12.35 5.24 4.44 4.67 4.48 4.18 3.55 3.61 3.52 3.43 3.82 3.80 4.46 4.455
Receivables Turnover 2.48 2.68 2.50 2.57 2.60 3.06 3.01 2.64 2.64 2.72 2.87 2.92 3.01 3.10 2.87 2.73 2.53 2.71 2.62 2.83 2.827
Payables Turnover 4.02 4.40 4.36 3.98 4.19 4.40 4.46 4.55 3.40 2.99 4.06 6.11 3.09 2.75 5.18 3.43 2.91 2.81 3.99 3.18 3.178
DSO 147 136 146 142 140 119 121 138 138 134 127 125 121 118 127 134 144 135 139 129 129.1 days
DIO 71 63 65 27 55 51 56 30 70 82 78 81 87 103 101 104 106 96 96 82 81.9 days
DPO 91 83 84 92 87 83 82 80 107 122 90 60 118 133 70 106 125 130 91 115 114.8 days
Cash Conversion Cycle 128 117 128 77 108 87 96 88 100 95 116 147 90 88 158 131 125 100 144 96 96.2 days
Fixed Asset Turnover snapshot only 1.427
Operating Cycle snapshot only 211.1 days
Cash Velocity snapshot only 1.565
Capital Intensity snapshot only 2.274
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -10.1% -2.2% -4.0% 5.1% 6.9% 10.6% 4.6% -10.1% -15.3% -24.4% -22.0% -14.7% -11.7% -7.4% -12.7% -17.5% -19.1% -11.7% -5.7% 6.6% 6.63%
Net Income 1.4% -40.1% -17.1% -6.6% 21.8% 10.6% 15.5% 17.5% 7.0% 29.2% 31.9% 14.7% 11.5% 0.6% -20.8% -47.6% -62.5% -75.5% -68.2% -49.9% -49.90%
EPS 1.4% -44.2% -22.9% -13.0% 13.4% 13.1% 16.5% 18.6% 8.0% 27.6% 34.1% 14.7% 11.5% 0.6% -21.5% -47.2% -62.6% -75.6% -68.5% -51.6% -51.61%
FCF -47.7% -40.7% -43.6% -70.4% -82.0% -71.8% 12.0% 1.7% 6.5% 3.3% 2.8% -26.6% -63.1% -1.1% -1.1% -92.1% -20.1% 4.5% 3.7% 3.5% 3.47%
EBITDA 3.1% -19.9% -1.2% 3.1% 8.8% -7.3% -9.1% -6.7% -5.0% 10.0% 13.3% -2.5% -13.5% -17.4% -37.5% -54.0% -52.3% -65.0% -52.7% -7.7% -7.72%
Op. Income 1.3% 27.1% -9.2% 3.8% 28.6% 10.7% 9.1% 9.8% 3.5% 12.4% 18.2% 1.1% -0.7% -2.1% -23.3% -49.6% -72.9% -93.2% -96.0% -86.5% -86.55%
OCF Growth snapshot only -40.60%
Asset Growth snapshot only 1.48%
Equity Growth snapshot only 1.74%
Debt Growth snapshot only 1.80%
Shares Change snapshot only 3.54%
Dividend Growth snapshot only 87.18%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -15.3% -10.4% -12.0% -8.9% -8.2% -7.4% -5.9% -7.3% -6.6% -6.5% -7.8% -7.0% -7.2% -8.2% -10.7% -14.2% -15.4% -14.8% -13.8% -9.2% -9.15%
Revenue 5Y 21.4% 16.3% 13.8% 11.6% 9.1% -0.7% -2.5% -8.1% -11.3% -9.7% -11.1% -10.4% -10.4% -11.1% -10.7% -10.9% -10.3% -7.7% -8.4% -6.7% -6.68%
EPS 3Y -15.4% -13.8% -14.9% -10.7% -8.8% — — — — -7.0% 6.4% 5.8% 10.9% 13.2% 7.1% -10.4% -23.3% -32.1% -30.8% -33.6% -33.57%
EPS 5Y -3.2% -2.0% -3.2% -0.4% -0.4% -5.1% -6.4% -5.4% -5.8% -1.6% -0.7% -0.7% -1.8% — — — — -27.7% -21.5% -21.3% -21.27%
Net Income 3Y -14.4% -10.2% -11.3% -7.4% -5.4% — — — — -5.0% 8.1% 8.0% 13.3% 12.9% 6.5% -10.9% -23.5% -31.7% -30.7% -33.0% -32.97%
Net Income 5Y -1.9% 0.6% -0.7% 1.0% 1.8% -3.0% -4.9% -3.5% -3.9% 0.7% 1.2% 1.4% 0.2% — — — — -26.7% -20.5% -19.9% -19.85%
EBITDA 3Y -11.0% -6.0% -8.4% -6.0% -8.2% — — — — -6.6% 0.6% -2.1% -3.6% -5.6% -13.6% -25.2% -26.8% -31.7% -30.6% -25.5% -25.45%
EBITDA 5Y 11.9% 13.0% 10.4% 9.1% 9.5% 0.9% -2.4% -4.1% -6.1% -3.3% -4.5% -5.5% -8.6% — — — — -25.1% -21.4% -16.8% -16.80%
Gross Profit 3Y -10.4% -5.9% -8.0% -6.0% -6.5% -4.5% -1.3% -2.1% -1.4% -1.0% -3.7% -3.7% -2.8% -5.2% -7.1% -11.5% -14.4% -16.1% -15.5% -15.0% -15.01%
Gross Profit 5Y 12.3% 9.8% 7.1% 5.7% 5.1% -1.0% -2.5% -4.8% -6.5% -5.5% -6.3% -5.6% -6.7% -6.3% -5.3% -7.7% -8.5% -8.2% -10.1% -10.1% -10.09%
Op. Income 3Y -21.7% -13.7% -15.7% -11.0% -10.2% — — — — 16.5% 5.4% 4.8% 9.8% 6.8% -0.4% -17.6% -34.7% -57.8% -67.0% -59.1% -59.07%
Op. Income 5Y -1.7% 1.6% -0.1% 1.0% 1.9% -6.8% -8.1% -8.2% -8.6% -4.4% -5.0% -4.8% -5.7% — — — — -36.2% -48.6% -39.9% -39.94%
FCF 3Y — — 79.8% -19.9% -38.0% -28.1% -9.3% -6.8% -10.9% -10.3% -13.4% -16.0% -20.6% — — -45.8% 30.4% -4.4% -29.7% -36.2% -36.20%
FCF 5Y — — — — — — — — — — 46.3% 0.6% -8.0% — — -45.7% -26.9% -31.9% -26.1% -26.8% -26.81%
OCF 3Y — 7.0% -4.8% -17.0% -20.6% -13.3% -8.8% -8.1% -10.2% -10.1% -10.0% -4.2% -7.1% -8.0% -6.8% 3.9% 9.7% -11.8% -22.2% -29.0% -29.02%
OCF 5Y 22.8% 85.5% 1.4% — — — — — — 9.5% 3.9% -4.1% -10.1% -7.7% -13.6% -14.1% -15.4% -21.7% -20.7% -16.2% -16.22%
Assets 3Y -6.7% -7.9% -9.1% -8.0% -6.8% -1.4% -0.8% -0.1% 2.0% 2.4% -2.7% -2.1% -0.4% 1.0% 0.6% 0.3% 0.2% 0.9% 1.1% 1.8% 1.75%
Assets 5Y 11.2% 1.0% 6.4% 6.0% 4.2% -3.5% 0.8% -4.8% -4.3% -5.4% -6.0% -5.4% -4.5% -0.2% 0.2% 0.7% 1.7% 2.5% -0.7% -0.2% -0.20%
Equity 3Y 7.9% 7.9% 7.6% 7.2% 6.8% 23.4% 19.9% 19.6% 18.6% 18.3% 6.7% 7.3% 7.3% 7.8% 7.1% 6.3% 5.5% 5.6% 5.0% 4.3% 4.33%
Book Value 3Y 6.6% 3.5% 3.3% 3.4% 2.9% 19.6% 15.8% 15.5% 14.5% 15.8% 5.1% 5.1% 5.1% 8.1% 7.7% 6.9% 5.7% 5.1% 4.9% 3.4% 3.40%
Dividend 3Y 36.5% -13.7% -12.1% 1.0% -30.4% -20.3% -21.2% -37.9% -11.4% 16.5% 18.6% 47.5% 23.4% -14.7% -14.0% -34.5% -31.3% 15.6% 16.1% 23.6% 23.57%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.15 0.19 0.15 0.18 0.15 0.17 0.54 0.90 0.82 0.74 0.85 0.89 0.90 0.88 0.92 0.97 0.90 0.72 0.84 0.86 0.862
Earnings Stability 0.16 0.01 0.03 0.03 0.03 0.01 0.00 0.00 0.00 0.13 0.15 0.16 0.16 0.42 0.47 0.38 0.36 0.32 0.19 0.41 0.410
Margin Stability 0.76 0.80 0.80 0.84 0.90 0.94 0.93 0.92 0.90 0.91 0.91 0.90 0.92 0.89 0.88 0.91 0.92 0.90 0.90 0.90 0.897
Rev. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
Earn. Growth Consistency 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 0 0 1 1
Earnings Persistence 0.20 0.50 0.50 0.50 0.50 0.96 0.94 0.93 0.97 0.88 0.87 0.94 0.95 1.00 0.92 0.81 0.50 0.50 0.50 0.80 0.800
Earnings Smoothness — 0.50 0.81 0.93 0.80 0.90 0.86 0.84 0.93 0.74 0.73 0.86 0.89 0.99 0.77 0.38 0.09 0.00 0.00 0.34 0.335
ROE Trend 0.16 0.19 0.18 0.18 0.19 -0.05 -0.00 0.00 0.00 0.02 0.02 0.01 0.00 0.00 -0.02 -0.04 -0.05 -0.07 -0.06 -0.05 -0.046
Gross Margin Trend 0.03 0.05 0.03 0.00 0.01 -0.01 -0.01 0.02 0.04 0.05 0.06 0.05 0.04 0.04 0.03 -0.01 -0.04 -0.08 -0.09 -0.10 -0.097
FCF Margin Trend -0.02 -0.01 -0.05 -0.11 -0.15 -0.15 -0.03 0.04 0.12 0.12 0.04 0.03 -0.03 -0.13 -0.15 -0.13 -0.06 -0.04 -0.00 -0.02 -0.019
Sustainable Growth Rate 0.6% 4.4% 3.6% 3.0% 6.2% 6.1% 6.1% 7.6% 6.8% 6.6% 6.7% 5.4% 5.6% 7.3% 5.4% 3.6% 2.2% -0.6% -0.5% 0.3% 0.30%
Internal Growth Rate 0.4% 2.6% 2.4% 2.0% 4.3% 4.3% 4.6% 5.8% 5.2% 5.1% 5.5% 4.4% 4.6% 6.1% 4.7% 3.0% 1.8% — — 0.2% 0.24%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.80 2.87 2.47 1.84 1.57 1.97 2.74 2.91 3.23 2.58 2.27 1.93 1.55 1.56 1.66 2.91 4.64 4.26 3.88 3.46 3.456
FCF/OCF 0.60 0.61 0.55 0.33 0.16 0.23 0.48 0.49 0.54 0.58 0.45 0.47 0.37 -0.06 -0.10 0.05 0.27 0.29 0.36 0.36 0.357
FCF/Net Income snapshot only 1.235
OCF/EBITDA snapshot only 1.263
CapEx/Revenue 8.5% 9.0% 8.3% 9.7% 11.5% 12.2% 11.8% 15.4% 16.3% 14.9% 17.5% 14.3% 13.3% 24.1% 23.1% 24.5% 21.6% 12.4% 10.8% 9.3% 9.30%
CapEx/Depreciation snapshot only 1.142
Accruals Ratio -0.09 -0.10 -0.07 -0.04 -0.03 -0.05 -0.10 -0.12 -0.14 -0.11 -0.10 -0.07 -0.04 -0.04 -0.04 -0.07 -0.09 -0.06 -0.05 -0.05 -0.046
Sloan Accruals snapshot only -0.012
Cash Flow Adequacy snapshot only 1.118
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 2.6% 1.2% 1.5% 2.7% 1.4% 1.2% 1.0% 0.8% 1.0% 2.0% 2.4% 3.2% 2.2% 1.3% 1.3% 0.8% 0.8% 2.2% 2.2% 1.9% 0.32%
Dividend/Share $0.44 $0.24 $0.23 $0.32 $0.16 $0.13 $0.13 $0.08 $0.12 $0.22 $0.22 $0.29 $0.24 $0.14 $0.14 $0.08 $0.08 $0.21 $0.21 $0.15 $0.03
Payout Ratio 92.7% 50.9% 50.8% 63.1% 28.6% 25.5% 23.9% 14.3% 20.7% 33.3% 31.7% 42.6% 37.1% 20.3% 25.0% 22.5% 31.8% 1.3% 1.2% 87.0% 86.95%
FCF Payout Ratio 55.1% 29.1% 37.3% 1.0% 1.1% 57.4% 18.1% 10.0% 11.8% 22.4% 30.7% 46.4% 64.2% — — 1.6% 25.8% 1.1% 88.9% 70.4% 70.40%
Total Payout Ratio 1.1% 51.5% 51.5% 63.7% 29.1% 25.5% 23.9% 14.3% 20.7% 33.3% 31.7% 42.6% 37.1% 20.3% 25.0% 22.5% 31.8% 1.3% 1.2% 87.0% 86.95%
Div. Increase Streak 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Chowder Number 1.66 -0.26 -0.22 0.18 -0.61 -0.43 -0.45 -0.73 -0.22 0.70 0.77 2.45 1.02 -0.37 -0.36 -0.72 -0.67 0.59 0.59 0.96 0.957
Buyback Yield 0.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 3.1% 1.2% 1.6% 2.7% 1.5% 1.2% 1.0% 0.8% 1.0% 2.0% 2.4% 3.2% 2.2% 1.3% 1.3% 0.8% 0.8% 2.2% 2.2% 1.9% 1.88%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.88 0.82 0.80 0.81 0.83 0.89 0.91 0.92 0.89 0.88 0.87 0.88 0.90 0.93 0.93 0.97 1.17 1.37 1.33 1.23 1.229
Interest Burden (EBT/EBIT) 0.87 0.89 0.89 0.92 0.93 0.89 0.91 0.92 0.92 0.95 0.96 0.96 0.95 0.98 0.97 0.96 0.97 0.95 0.96 1.03 1.029
EBIT Margin 0.10 0.11 0.11 0.11 0.11 0.10 0.10 0.12 0.13 0.16 0.17 0.17 0.16 0.16 0.14 0.10 0.06 0.03 0.03 0.03 0.033
Asset Turnover 0.65 0.66 0.63 0.66 0.67 0.69 0.69 0.61 0.57 0.53 0.54 0.53 0.51 0.48 0.47 0.43 0.41 0.42 0.43 0.44 0.443
Equity Multiplier 1.76 1.72 1.54 1.55 1.49 1.48 1.40 1.40 1.38 1.35 1.29 1.28 1.28 1.27 1.22 1.24 1.24 1.25 1.21 1.24 1.237
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.48 $0.46 $0.45 $0.50 $0.54 $0.52 $0.52 $0.59 $0.59 $0.67 $0.70 $0.68 $0.66 $0.67 $0.55 $0.36 $0.25 $0.16 $0.17 $0.17 $0.17
Book Value/Share $6.50 $6.07 $6.25 $6.36 $6.51 $6.64 $6.74 $6.90 $7.05 $7.09 $7.42 $7.42 $7.54 $7.68 $7.82 $7.77 $7.69 $7.70 $7.78 $7.63 $7.62
Tangible Book/Share $6.04 $5.69 $5.88 $5.99 $6.14 $6.32 $6.43 $6.61 $6.75 $6.75 $7.09 $7.10 $7.22 $7.32 $7.47 $7.43 $7.35 $7.37 $7.46 $7.34 $7.34
Revenue/Share $6.32 $5.82 $5.95 $6.26 $6.29 $6.58 $6.27 $5.68 $5.37 $4.92 $4.97 $4.84 $4.75 $4.55 $4.30 $4.03 $3.83 $4.01 $4.02 $4.15 $4.15
FCF/Share $0.81 $0.81 $0.61 $0.31 $0.14 $0.23 $0.69 $0.85 $1.03 $1.00 $0.72 $0.62 $0.38 $-0.06 $-0.09 $0.05 $0.30 $0.20 $0.24 $0.21 $0.21
OCF/Share $1.35 $1.33 $1.11 $0.92 $0.86 $1.04 $1.43 $1.72 $1.90 $1.73 $1.59 $1.31 $1.01 $1.05 $0.91 $1.05 $1.14 $0.70 $0.67 $0.60 $0.60
Cash/Share $1.85 $1.98 $1.63 $1.74 $1.95 $2.34 $2.23 $2.40 $2.43 $2.52 $2.34 $2.35 $2.23 $2.32 $2.05 $2.32 $2.33 $2.40 $2.16 $2.65 $2.65
EBITDA/Share $1.22 $1.22 $1.22 $1.25 $1.23 $1.16 $1.12 $1.18 $1.18 $1.26 $1.28 $1.15 $1.02 $1.04 $0.80 $0.53 $0.49 $0.36 $0.37 $0.48 $0.48
Debt/Share $1.57 $1.25 $1.23 $1.11 $1.11 $0.83 $0.66 $0.49 $0.45 $0.19 $0.18 $0.15 $0.14 $0.18 $0.09 $0.09 $0.28 $0.22 $0.15 $0.24 $0.24
Net Debt/Share $-0.28 $-0.74 $-0.40 $-0.63 $-0.84 $-1.51 $-1.57 $-1.90 $-1.97 $-2.33 $-2.16 $-2.20 $-2.08 $-2.15 $-1.96 $-2.23 $-2.05 $-2.19 $-2.00 $-2.41 $-2.41
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 4.158
Altman Z-Prime snapshot only 8.466
Piotroski F-Score 6 6 5 6 8 8 9 8 8 7 8 8 7 6 5 6 4 4 4 5 5
Beneish M-Score -2.93 -2.86 -2.82 -2.58 -2.74 -8.26 -3.19 -3.59 -3.55 -3.28 -3.28 -2.97 -2.85 -2.18 -2.53 -2.52 -2.79 -1.97 -2.58 -1.48 -1.481
Ohlson O-Score snapshot only -10.101
ROIC (Greenblatt) snapshot only 2.17%
Net-Net WC snapshot only $3.23
EVA snapshot only $-183563278.60
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AAA
Credit Score 85.72 87.18 87.14 85.79 86.36 94.21 96.04 95.94 96.37 95.95 96.15 96.22 96.45 91.77 92.17 96.53 96.25 95.05 95.97 95.55 95.551
Credit Grade snapshot only 1
Credit Trend snapshot only -0.976
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 93
Sector Credit Rank snapshot only 92

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms